Market Overview

UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic

Related UNH
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Healthcare ETFs Leading the Pack This Q2 Earnings - ETF News And Commentary
UnitedHealth Raises Dividend 34% (Fox Business)

Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.

Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."

UnitedHealth Group closed at $55.21 on Wednesday.

Posted-In: OppenheimerAnalyst Color Upgrades Analyst Ratings

 

Related Articles (UNH)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters